Related Experiment Video
Updated: Apr 16, 2026

4D Imaging of Protein Aggregation in Live Cells
Published on: April 5, 2013
Legal but lethal: functional protein aggregation at the verge of toxicity
Angelika Falsone1, S Fabio Falsone1
1Institute of Pharmaceutical Sciences, University of Graz Graz, Austria.
Abstract:
Many neurodegenerative disorders are linked to irreversible protein aggregation, a process that usually comes along with toxicity and serious cellular damage. However, it is emerging that protein aggregation can also serve for physiological purposes, as impressively shown for prions. While the aggregation of this protein family was initially considered exclusively toxic in mammalians organisms, it is now almost clear that many other proteins adopt prion-like attributes to rationally polymerize into higher order complexes with organized physiologic roles. This implies that cells can tolerate at least in some measure the accumulation of inherently dangerous protein aggregates for functional profit. This review summarizes currently known strategies that living organisms adopt to preserve beneficial aggregation, and to prevent the catastrophic accumulation of toxic aggregates that frequently accompany neurodegeneration.
Insights
Protein aggregation, often linked to neurodegenerative diseases, can also serve beneficial physiological roles. Organisms have strategies to manage beneficial protein aggregation while preventing toxic accumulation.
Area of Science:
- Molecular Biology
- Neuroscience
- Cell Biology
Background:
- Protein aggregation is a hallmark of neurodegenerative disorders, typically associated with cellular toxicity and damage.
- Emerging evidence suggests that protein aggregation can also fulfill essential physiological functions, exemplified by prions.
- While initially viewed as solely toxic, many proteins exhibit prion-like properties for organized polymerization into functional complexes.
Purpose of the Study:
- To review the strategies employed by living organisms to maintain beneficial protein aggregation.
- To explore mechanisms preventing the detrimental accumulation of toxic protein aggregates.
Main Methods:
- Literature review of studies on protein aggregation in various organisms.
- Analysis of cellular and molecular mechanisms governing protein polymerization.
- Examination of prion biology and prion-like protein behavior.
Main Results:
- Cells can tolerate the accumulation of potentially harmful protein aggregates for functional benefits.
- Organisms possess distinct strategies to differentiate between beneficial and detrimental protein aggregation.
- Prion-like attributes are utilized by various proteins for organized physiological roles.
Conclusions:
- Protein aggregation is a complex biological process with both pathological and physiological implications.
- Understanding the balance between beneficial and toxic aggregation is crucial for neurodegenerative disease research.
- Cellular mechanisms exist to harness protein aggregation for functional advantage, challenging the solely detrimental view.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Molecular Chaperones and Protein Folding
The...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Export of Misfolded Proteins out of the ER

